Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
2,20:3,19-Dimethano-2,3,4a,5a,6a,7a,8a,9a,10a,11a, 12a,13a,14a,15a,16a,17a,19 ,20,21a,22a,23a,24a,25a,26a,27a,28a,29a,30a,31a,32a,33a,34a-dotriacontaazabispentaleno [1''',6''':5'',6'',7''] cycloocta[1'',2'',3'':3'',4'']pentaleno[1'',6'':5',6',7']cycloocta[1',2',3':3',4']pentaleno[1',6':5,6,7]cycloocta[1,2,3-gh:1',2',3'-g'h']cycloocta[1,2,3-cd:5,6,7-c'd']dipentalene-1,4,6,8,10,12,14,16,18,21,23,25,27,29,31,33-hexadecone, hexadecahydro-, stereoisomer,2,18:3,17-Dimethano-2,3, ,4a,5a,6a,7a,8a,9a,10a,11a,12a,13a,14a,15a,17,18,19a, 20a,21a,22a,23a,24a, 25a,26a,27a,28a,29a,30a-octacosaazabispentaleno[1''',6''':5'',6'',7'']cycloocta [1'',2'',3'':3'',4''] pentaleno[1'',6'':5',6',7']cycloocta[1',2',3':3',4']pentaleno[1',6':5,6,7]cycloocta[1,2,3-cd:1',2',3'-gh]pentalene-1,4,6,8,10,12,14,16,19,21,23,25,27,29-tetradecone, tetradecahydro-, stereoisomer, 1H,4H,12H,15H-2,14:3,13-Dimethano-5H,6H,7H,8H,9H,10H,11H,16H,17H,18H,19H,20H,21H,22H-2,3,4a,5a,6a,7a,8a,9a,10a,11a,13,14,15a,16a,17a,18a,19a,20a,21a,22a-eicosaazabispentaleno [1'',6'':5',6',7']cycloocta[1',2',3':3',4']pentaleno[1',6':5,6,7]cycloocta[1,2,3-cd:1',2',3'-gh]pentalene-1,4,6,8,10,12,15,17,19,21-decone, decahydro-, stereoisomer
EC number: 946-188-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Oral Toxicity: LD50 >5000 mg/kg bw female Wistar rats (read-across from analogue substance).
LC50 (rat, inhalation, 4h) > 5.35 mg/L
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Route of administration:
- oral: gavage
- Vehicle:
- other: Methyl cellulose 1%
- Doses:
- The starting dose level (5000 mg/kg bw) was selected at the request of the Sponsor.
Initially, one female was treated at a dose level of 5000 mg/kg bw of CUCURBIT[8]URIL. The test item did not cause mortality; therefore further two
animals were treated at the same dose level. The test item did not cause mortality in these animals, so no further testing was required according to
OECD 423 and Commission Regulation (EC) NO 440/2008 of 30 May 2008, B.1.Tris. - No. of animals per sex per dose:
- 3 female rats were exposed to a single dose of 5000mg/kg bw
- Control animals:
- no
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, the acute oral LD50 value of the test item CUCURBIT[8]URIL was found to be above 5000 mg/kg bw in female
CRL: (WI) rats. According to the GHS criteria, CUCURBIT[8]URIL can be ranked as “Unclassified” for acute oral exposure. - Executive summary:
The objective of the study was to assess the toxicity of test item CUCURBIT[8]URIL when administered as a single oral gavage dose to rats. The results of the study allow the test item to be ranked according to most classification systems currently used. Study performed in accordance with the study plan, OECD 423 (17th December 2001), Commission Regulation (EC) NO 440/2008 of 30 May 2008, B.1.Tris, EPA Health Effects Test Guidelines (OCSPP 8770.1100), United States, EPA 712-C-98-190 (1998) and the Principles of Good Laboratory Practice (Hungarian GLP Regulations: 42/2014. (VIII. 19.) EMMI decree of the Ministry of Human Capacities which corresponds to the OECD GLD, ENV/MC.CHEM (98)17).
Under the conditions of this study, the acute oral LD50 value of the test item CUCURBIT[8]URIL was found to be above 5000 mg/kg bw in female CRL: (WI) rats. According to the GHS criteria, CUCURBIT[8]URIL can be ranked as “Unclassified” for acute oral exposure.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD0
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- A GLP study was performed with an analogue substance according to OECD Guideline 423, EU Method B1. Tris and US EPA Procedure OCSPP 870.1100
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2020/21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 433 (Acute Inhalation Toxicity: Fixed Concentration Procedure)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed concentration procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Mass median aerodynamic diameter (MMAD):
- >= 2.7 - <= 2.8 µm
- Geometric standard deviation (GSD):
- >= 2.33 - <= 2.58
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- targeted: 5 mg/l, achieved: 5.35 mg/l
- No. of animals per sex per dose:
- 1 male and 1 female for the sighting study, 5 male animals for the main study
- Control animals:
- no
- Preliminary study:
- In 1 male and 1 female absence of mortality or toxicity at a target exposure level of 5 mg/L
- Key result
- Sex:
- male
- Dose descriptor:
- LC0
- Effect level:
- 5.35 mg/L air
- Based on:
- test mat.
- Mortality:
- No mortality was observed.
- Clinical signs:
- salivation
- Body weight:
- On the day following exposure (Day 2), body weight loss was evident in 4/5 males exposed to 5.35 mg/L. The group mean body weight was comparable to Day 1 values by the next weighing occasion (Day 7) and continued to increase for the remainder of the observation period.
The changes in body weight gain on Day 2 are considered to be a consequence of the exposure (duration and removal of food and water), and therefore not test item-related. - Gross pathology:
- The macroscopic examination after a single exposure followed by a fourteen day observation period for males exposed to 5.35 mg/L revealed no abnormalities.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LC50 (4-hour) is in excess of 5.35 mg/L for male rats.
- Executive summary:
There were no test item-related deaths, macropathology findings or effects on body weight in an acute nose-only inhalation study in rats in accordance with OECD guideline 433. Under the conditions of this study the LC50 (4-hour) is in excess of 5.35 mg/L for male rats.
Reference
Salivation was seen in 2/5 males on return to home cage, resolving by the end of the working day check.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC0
- Value:
- 5.35 mg/L air
- Physical form:
- inhalation: aerosol
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The single-dose oral toxicity of Cucurbit[8]uril hydrochloride hydrate was performed according to the acute toxic class method in CRL: (WI) rats. Initially, one female was treated at a dose level of 5000 mg/kg bw by gavage after an overnight food withdrawal. Food was made available again 3 hours after the treatment. The test item was administered formulated in Methyl cellulose 1% at a concentration of 500 mg/mL at a dosing volume of 10 mL/kg bw. The test item did not cause mortality and two further animals were treated at the same dose level. Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weight was measured on Days -1, 0 and 7 and Day 14 before necropsy. All animals were subjected to a necropsy and a macroscopic examination.
The test substance did not cause mortality in these animals, and did not cause any test substance related effects on the animals. There were no changes in body weight gains or any macroscopic findings. Therefore, no further testing was required according to OECD 423 and Commission Regulation (EC) NO 440/2008 of 30 May 2008, B.1.Tris. Under the conditions of this study, the acute oral LD50 value of Cucurbit[8]uril hydrochloride hydrate was found to be above 5000 mg/kg bw in female CRL: (WI) rats.
Justification for classification or non-classification
Based on the available data, the test substance does not require classification for acute oral and inhalation toxicity according to the CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.